Formation of highly ordered thin films of perfluorinated carboxylic acids and azobenzenes by thermal evaporation

Stearic acid, two short chain perfluorinated carboxylic acids, C₉F₁₉COOH and C₁₁F₂₃COOH, and two amphiphilic azobenzene derivatives were thermally evaporated onto a variety of substrates in vacuo. The resulting films (0.1–1.0 ωm thick) were studied by low angle X-ray diffraction and polarizing microscopy. Substrate temperature was a critical factor in determining film quality. For the azobenzenes, the structures obtained gave up to eight Bragg reflections and appeared to be identical to structures obtained by the much slower Langmuir-Blodgett (LB) technique. For the fluorocarbons up to 14 Bragg reflections were observed, corresponding to bilayer spacings of 2.79 nm (C₉) and 3.19 nm (C₁₁), indicating highly ordered structures which could not be achieved at all by the LB technique. The relative peak intensities before and after incorporating Ag⁺ ions into the structures confirm the bilayer-type structure. It is suggested that the thermal evaporation method has considerable potential for producing ordered films of non-polymeric organic materials where the LB technique is either too slow or unusable.     

An International Marine-Atmospheric 222Rn Measurement Intercomparison in Bermuda Part I: NIST Calibration and Methodology for Standardized Sample Additions

As part of an international ²²²Rn measurement intercomparison conducted at Bermuda in October 1991, NIST provided standardized sample additions of known, but undisclosed (“blind”) ²²²Rn concentrations that could be related to U.S. national standards. The standardized sample additions were obtained with a calibrated ²²⁶Ra source and a specially-designed manifold used to obtain well-known dilution factors from simultaneous flow-rate measurements. The additions were introduced over sampling periods of several hours (typically 4 h) into a common streamline on a sampling tower used by the participating laboratories for their measurements. The standardized ²²²Rn activity concentrations for the intercomparison ranged from approximately 2.5 Bq · m⁻³ to 35 Bq · m⁻³ (of which the lower end of this range approached concentration levels for ambient Bermudian air) and had overall uncertainties, approximating a 3 standard deviation uncertainty interval, of about 6 % to 13 %. This paper describes the calibration and methodology for the standardized sample additions.     

Symptomatic improvement following emergency department management of asthma: a pilot study of intramuscular dexamethasone versus oral prednisone

Systemic corticosteroid therapy is an established adjunct to beta-adrenergic medications in acute exacerbations of asthma. To date, no study has defined the role of long-acting intramuscular preparations of corticosteroids in pediatric patients with asthma. A pilot study was conducted to prospectively compare symptomatic improvement following a single injection of intramuscular dexamethasone (IMD) to a 3-day regimen of oral prednisone (OP) for children with mild to moderate wheezing episodes that are responsive to nebulized medications in the Pediatric Emergency Department (PED). The following children presenting with acute exacerbations of asthma to the PED were eligible for enrollment: age 3-16 years; more than two prior wheezing episodes; mild to moderate wheezing; and oxygen saturation 95% or more in room air. The study patients were randomly assigned to receive either IMD (n = 21) or OP (n = 21) in addition to a standardized treatment regimen of nebulized albuterol. All of the children were clinically rated for wheezing severity by the Pulmonary Index (PI) score at regular intervals during the study. Discharge home was based on clinical improvement during treatment in the PED; patients who were admitted to the hospital were removed from the study. Follow-up was conducted the fifth day after discharge from the ED either by clinic visit or by telephone. Patients were assessed for symptomatic improvement and relapse or clinical deterioration during the study period by a clinician blinded to group assignment. Forty-two children participated in this pilot study. There were no significant differences between the IMD and OP groups for gender or age. Mean ages were: 82 months (SD 46 months), IMD group; 63 months (SD 36 months), OP group. Clinical progress (based on PI) with treatment in the PED was the same in both groups: pretreatment median, PI = 6; PED discharge median, PI = 2. None of the study patients were hospitalized during the follow-up period, and all reported symptomatic improvement since initial treatment. The data of this pilot study suggest that IMD may be a feasible alternative to OP for treatment of acute wheezing episodes in children with asthma. IMD provides sufficient treatment to prevent clinical deterioration within 5 days after initial therapy for mild to moderate pediatric exacerbations of asthma that are responsive to nebulized medications.     

Plutonium anomalies in attic dust and soils at locations surrounding the Nevada Test Site

Attic dust and soil samples were collected during the Summer of 1996 and the Spring of 1997 in southern Nevada and southern Utah. Analysis of the samples for radiocesium and plutonium give activity ratios of radiocesium/plutonium that range from 0.7 +/- 0.1 to 27 +/- 2, well below the world-wide fallout ratio of 34 +/- 4 (as of 1 July 1997). This indicates anomalous plutonium throughout the region, including areas to the south of the Nevada Test Site (NTS), generally believed to have received only world-wide fallout. Safety tests and above-ground detonations that resulted in incomplete fission, conducted at the NTS during the 1950's and 1960's, are likely sources of this excess plutonium.     

Renoprotective differences between perindopril and enalapril in the diabetic hypertensive rat do not reflect glomerular angiotensin-converting enzyme activity

1. The various angiotensin-converting enzyme inhibitors have structural differences which affect their affinities for the catalytic sites on converting enzyme. We postulated that such differences might result in differences in renoprotective efficacy. We investigated this in the diabetic spontaneous hypertensive rat. We also investigated whether these differences might reflect variations in glomerular or plasma angiotensin-converting enzyme activity. 2. One week after induction of diabetes, rats were started on antihypertensive therapy: enalapril, 10 mg.day-1.kg-1, or perindopril, 4 mg.day-1.kg-1, in the drinking water. After 3 months, the rats were killed, blood samples were taken and tissues were harvested. Angiotensin-converting enzyme activity in isolated glomeruli and plasma was measured by fluorimetric assay. Glomerular protein content was also determined. 3. Urinary protein excretion was significantly lower in perindopril-treated rats than in either controls (P < 0.0005) or enalapril-treated rats (P < 0.05). Glomerular protein content was also lower in perindopril-treated rats (P < 0.05 versus enalapril; P < 0.005 versus control). There was no difference in glomerular angiotensin-converting enzyme activity between the two inhibitors although both were lower than control values (enalapril P < 0.025; perindopril P < 0.025). Plasma angiotensin-converting enzyme activity was significantly lower in the perindopril group than in either control (P < 0.005) or the enalapril group (P < 0.01). 4. We conclude that in the spontaneous hypertensive rat with streptozotocin-induced diabetes, perindopril is more effective than enalapril in reducing proteinuria and glomerular protein accumulation. This difference does not result from differences in glomerular-converting enzyme activity.     

Re‐evaluation of the Optimal Operating Conditions for the Primary End of an Integrated Steel Plant using Multi‐objective Genetic Algorithms and Nash Equilibrium

Some existing work on optimizing the operational cost of the primary end of an integrated steel plant containing two blast furnaces utilizing both pellets and sinters, an electric furnace and a basic oxygen furnace was further advanced using a multi‐objective genetic algorithm, along with a Nash equilibrium analysis. The new formulation was able to improve the earlier results very significantly, suggesting the efficacy of the multi‐objective approach over the more conventional single objective genetic algorithms.     

Cardiorespiratory kinetics and femoral artery blood velocity during dynamic knee extension exercise

The kinetics of femoral artery mean blood velocity (MBV; measured by pulsed Doppler) and whole body oxygen uptake (VO2; measured breath by breath) were assessed from the time constant during the on (tau on) and off (tau off) transients to step changes in work rate between complete rest and dynamic knee extension (KE) exercise. Six healthy men performed 5 min of seated KE exercise, with each leg alternately raising and lowering a weight (10% maximum voluntary contraction) over a 2-s duty cycle. Because kinetic analysis of VO2 kinetics during KE exercise is a new approach, the VO2 responses were also evaluated during the on and off transitions to the more familiar upright cycling exercise in which the magnitude of increase in VO2 and cardiac output was similar to that during KE exercise. During KE exercise, VO2 tau on [mean 72.2 +/- 11.2 (SE) s] was slower than VO2 tau off (33.3 +/- 1.8 s; P < 0.01). Cardiac output, measured with impedance cardiography, was not different for tau on (67.1 +/- 20.0 s) compared with that for tau off (52.9 +/- 7.6 s). Likewise, MBV tau on (34.5 +/- 3.9 s) was not different from tau off (35.3 +/- 3.2 s). During cycling, the VO2 tau on (18.0 +/- 2.4 s) and tau off (30.7 +/- 1.2 s) were both faster than KE VO2 tau on (P < 0.01). Even though the MBV kinetics indicated a rapid adaptation of blood flow during KE exercise, there was a slow adaptation of VO2. A transient hyperemia immediately on cessation of KE exercise, indicated by both MBV and calculated systemic vascular conductance responses, suggested that blood flow might have been inadequate and could have contributed to the delayed adaptation of VO2 at the onset of exercise, although other explanations are possible.